Wilmington, Delaware, Nov. 27, 2023 (GLOBE NEWSWIRE) -- According to RationalStat’s most recent industry analysis, the Global Non-Muscle Invasive Bladder Cancer Market value is estimated at US$ 2.5 billion in 2023 and is expected to rise at a strong CAGR of over 5.4% over the forecast period of 2023-2030.
Market Definition, Market Scope, and Report Overview
Non-muscle invasive bladder cancer (NMIBC) is a kind of bladder cancer that is confined to the bladder's innermost lining, known as the urothelium, and does not invade the muscular layers of the bladder wall. NMIBC is a type of early-stage bladder cancer that is commonly detected when cancer cells are discovered in the bladder lining during a cystoscopy and biopsy.
Bladder cancer, which includes NMIBC, is one of the most frequent cancers worldwide. The increased incidence of bladder cancer, which can be linked to factors such as ageing populations, tobacco use, and chemical exposure, is contributing to the growth of the NMIBC market.
- According to a deep-dive market assessment by RationalStat, the global Non-Muscle Invasive Bladder Cancer market has been analyzed on the basis of market segments, including stage, treatment, route of administration, distribution channel, and geography/regions (including North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa, and Asia Pacific). The report also offers global and regional market sizing for the historical period of 2019-2022 and the forecast period of 2023-2030.
- Market intelligence for the global Non-Muscle Invasive Bladder Cancer market covers market sizes on the basis of market value (US$/EUR Million) and volume (Liters) by various products/services/equipment, demand assessment across the key regions, customer sentiments, price points, cost structures, margin analysis across the value chain, financial assessments, historical and forecast data, key developments across the industry, import-export data, trade overview, components market by leading companies, etc.
- In addition, the long-term sector and products/services 10-year outlook and its implications on the global Non-Muscle Invasive Bladder Cancer market. It also includes the industry's current state – Production Levels, Capacity Utilization, Tech quotient, etc. Key information will be manufacturing capacity by country, installed base, import volumes, market size, key players, market size, dynamics, market data, insights, etc.
Request A Customization- https://store.rationalstat.com/store/global-non-muscle-invasive-bladder-cancer-market/#tab-ux_global_tab
Global Non-Muscle Invasive Bladder Cancer Market: Segmental and Market Share Analysis
- On the basis of treatment, chemotherapy segment is the largest growing segment of non-muscle invasive bladder cancer market. Due to the high prevalence of non-muscle invasive bladder cancer and the effectiveness of chemotherapy in treating this condition.
Report Synopsis
| Report Metrics | Details |
| Base Year | 2023 |
| Forecast Period | 2023-2030 |
| Base Year Market Size | US$ 2.5 billion |
| Market Size Forecast | US$ 3.6 billion |
| Growth Rate | 5.4% |
| Dominant Segment | Chemotherapy |
| Dominant Region | North America |
| Key Market Drivers |
|
| Companies Profiled |
|
Explore more about this report- https://store.rationalstat.com/store/global-non-muscle-invasive-bladder-cancer-market/#tab-ux_global_tab
Competition Analysis and Market Structure
Some leading players adopt various strategies in order to reinforce their market share and gain a competitive edge over other competitors in the market. Mergers & acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players. Some of the key developments in the global non-muscle invasive bladder cancer market include.
- In November 2023, Prokarium, a biopharmaceutical company, announced that the FDA approved the company's Investigational New Drug (IND) application for their immunotherapy ZH9. The approval allows for the start of ZH9's clinical development program in the US, with a focus on patients with non-muscle invasive bladder cancer.
Some of the prominent players and suppliers operating and contributing significantly to the global non-muscle invasive bladder cancer market growth include Pfizer Inc, GlaxoSmithKline, Celgene Corporation, Sanofi S.A., F. Hoffmann-La Roche, Novartis International AG, Eli Lilly and Co, AstraZeneca plc, Bristol-Myers Squibb, Taris Biomedical LLC, Merck & Co Inc, and Altor BioScience, among others.
Get A Free Sample- https://store.rationalstat.com/store/global-non-muscle-invasive-bladder-cancer-market/#tab-ux_global_tab
RationalStat has segmented the global non-muscle invasive bladder cancer market based on stage, treatment, route of administration, distribution channel and region
- Global Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Stage
- Carcinoma in Situ (CIS)
- T1 Stage
- Ta Stage
- Global Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Treatment
- Immunotherapy
- Chemotherapy
- Surgery
- Intravesical Therapy
- Others
- Global Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Route of Administration
- Systemic
- Intravesical
- Others
- Global Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Region
- North America Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Country
- US
- Canada
- Latin America Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Country
- Brazil
- Mexico
- Rest of Latin America
- Western Europe Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Country
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Country
- Russia
- Poland
- Hungary
- Other CIS Countries
- Rest of Eastern Europe
- Asia Pacific Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Country
- China
- Japan
- India
- South Korea
- Australia
- ASEAN
- Indonesia
- Thailand
- Philippines
- Vietnam
- Malaysia
- Rest of ASEAN
- Rest of Asia Pacific
- Middle East & Africa Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Country
- GCC
- Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Rest of the GCC
- South Africa
- Nigeria
- Turkey
- Rest of the Middle East & Africa
- GCC
- North America Non-Muscle Invasive Bladder Cancer Market Value (US$ Million), Volume (Liters), and Market Share (2019-2030) Analysis by Country
For more information about this report- https://store.rationalstat.com/store/global-non-muscle-invasive-bladder-cancer-market/
Key Questions Answered in the Non-Muscle Invasive Bladder Cancer Report:
- What will be the market value of the global Non-Muscle Invasive Bladder Cancer market by 2030?
- What is the market size of the global Non-Muscle Invasive Bladder Cancer market?
- What are the market drivers of the global Non-Muscle Invasive Bladder Cancer market?
- What are the key trends in the global Non-Muscle Invasive Bladder Cancer market?
- Which is the leading region in the global Non-Muscle Invasive Bladder Cancer market?
- What are the major companies operating in the global Non-Muscle Invasive Bladder Cancer market?
- What are the market shares by key segments in the global Non-Muscle Invasive Bladder Cancer market?
Running a year End discount of 20%-https://store.rationalstat.com/store/global-non-muscle-invasive-bladder-cancer-market/#tab-ux_global_tab
Explore Our Trending Reports
- Global Metastatic Colorectal Cancer Therapeutics Market- Global metastatic colorectal cancer therapeutics market is anticipated to attain a value of US$ 7.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.2% during the forecast period.
- Global Dermatology Lasers Market- Global Dermatology Lasers Market is expected to grow at a CAGR of 7.3% over the forecast period of 2022-2028
- Global Pharmaceutical Contract Manufacturing Market- Global pharmaceutical contract manufacturing market is anticipated to grow at a CAGR of 7.9%
- Global Biologics Contract Manufacturing Market- Global biologics contract manufacturing market is anticipated to grow at a CAGR of 9.5%
- Global Benign Prostatic Hyperpl Medication - Global Benign Prostatic Hyperpl Medication Market is expected to grow at a CAGR of 5.0% over the forecast period of 2022-2028.
- Global Red Light Therapy Device Market-Global Red Light Therapy Device Market is expected to grow at a significant CAGR of 4.2% over the forecast period of 2022-2028.
- US Pharmacy Market- US pharmacy market is anticipated to attain a value of US$ 706 million by 2030, growing at a compound annual growth rate (CAGR) of 3.9% during the forecast period.
- Global Retinoblastoma Treatment Market- global retinoblastoma treatment market is anticipated to attain a value of US$ 3.0 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period.
- Global Pet Relaxants Market- Global pet relaxants market is anticipated to attain a value of US$ 443 million by 2030, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period.
- Global Pet CBD (cannabidiol) Market- Global Pet CBD (cannabidiol) Market is expected to grow at a CAGR of 12.0% over the forecast period of 2022-2028
- Global Medical Rehabilitation Service Market- Global Medical Rehabilitation Service Market is expected to grow at a CAGR of 6.1% over the forecast period of 2022-2028
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Download Key Insights and Market Data - Raise a Query
About RationalStat LLC
RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client’s needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.
Contact
RationalStat LLC
Kimberly Shaw,
Content and Press Manager
US Phone: +1 302 803 5429
UK Phone: +44 203-287-1245
LinkedIn | Facebook | Twitter | Instagram | Pinterest
